loading
前日終値:
$171.00
開ける:
$170.56
24時間の取引高:
662.55K
Relative Volume:
0.58
時価総額:
$10.22B
収益:
$4.09B
当期純損益:
$-404.84M
株価収益率:
-24.91
EPS:
-6.7469
ネットキャッシュフロー:
$1.24B
1週間 パフォーマンス:
-0.72%
1か月 パフォーマンス:
-0.76%
6か月 パフォーマンス:
+43.33%
1年 パフォーマンス:
+37.32%
1日の値動き範囲:
Value
$167.00
$171.51
1週間の範囲:
Value
$165.01
$171.70
52週間の値動き範囲:
Value
$95.49
$182.99

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1119)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,800
Name
Twitter
@jazzpharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

JAZZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
168.19 10.39B 4.09B -404.84M 1.24B -6.7469
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.16 118.58B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
751.89 79.40B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
815.50 51.18B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
362.90 48.88B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
338.94 37.49B 4.98B 69.59M 525.67M 0.5197

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
06:37 AM

Dip Buying: Why is Jazz Pharmaceuticals plc stock going upEarnings Risk Report & Stepwise Trade Signal Implementation - baoquankhu1.vn

06:37 AM
pulisher
Jan 21, 2026

Acute Myeloid Leukemia Market Forecast to 2034: 7MM Opportunity, Strong CAGR, 43,500 Annual Cases, and Pipeline-Driven Growth | DelveInsight - Barchart.com

Jan 21, 2026
pulisher
Jan 19, 2026

Lmcg Investments LLC Trims Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 19, 2026
pulisher
Jan 19, 2026

Aug Mood: Will Jazz Pharmaceuticals plc benefit from green energy policiesTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 18, 2026

Jazz Pharmaceuticals (JAZZ) Is Up 5.1% After Monetizing FDA Voucher And Expanding Oncology Collaboration - Yahoo Finance

Jan 18, 2026
pulisher
Jan 17, 2026

Is Jazz (JAZZ) Quietly Recasting Its Oncology Strategy Through HER2 Partnerships And Voucher Monetization? - simplywall.st

Jan 17, 2026
pulisher
Jan 17, 2026

New York State Teachers Retirement System Sells 9,223 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 17, 2026
pulisher
Jan 16, 2026

JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug - MSN

Jan 16, 2026
pulisher
Jan 16, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Recent Share Price Momentum - simplywall.st

Jan 16, 2026
pulisher
Jan 15, 2026

JPM26: Jazz sells PRV for $200m, targets deals in 2026 - Pharmaceutical Technology

Jan 15, 2026
pulisher
Jan 15, 2026

JAZZJazz Pharmaceuticals Plc Latest Stock News & Market Updates - Stock Titan

Jan 15, 2026
pulisher
Jan 15, 2026

Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate - BioSpace

Jan 15, 2026
pulisher
Jan 14, 2026

Jazz Pharmaceuticals stock rating reiterated at Outperform by RBC Capital - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 14, 2026

Jazz Pharmaceuticals Soars with Promising HERIZON-GEA-01 Results - timothysykes.com

Jan 14, 2026
pulisher
Jan 14, 2026

Jazz sells priority review voucher for $200 million - First Word Pharma

Jan 14, 2026
pulisher
Jan 13, 2026

JAZZ: Sharpened rare disease focus, record growth, and pivotal zanidatamab results drive future milestones - TradingView — Track All Markets

Jan 13, 2026
pulisher
Jan 13, 2026

JAZZ: Rare disease focus, record revenues, and zanidatamab's breakthrough in GEA drive future growth - TradingView — Track All Markets

Jan 13, 2026
pulisher
Jan 13, 2026

JAZZ: Refined rare disease focus, strong 2025 results, and new launches drive future growth - TradingView — Track All Markets

Jan 13, 2026
pulisher
Jan 13, 2026

Baird reiterates Underperform rating on Jazz Pharmaceuticals stock at $209 By Investing.com - Investing.com Nigeria

Jan 13, 2026
pulisher
Jan 13, 2026

Jazz Pharmaceuticals PLC $JAZZ Holdings Lessened by Polaris Capital Management LLC - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Jazz Pharmaceuticals price target raised to $235 from $210 at Needham - Yahoo Finance

Jan 13, 2026
pulisher
Jan 12, 2026

Jazz Pharmaceuticals stock price target raised to $263 from $247 at BofA - Investing.com Nigeria

Jan 12, 2026
pulisher
Jan 12, 2026

Jazz Pharmaceuticals stock price target raised to $230 by Truist Securities - Investing.com Nigeria

Jan 12, 2026
pulisher
Jan 12, 2026

Jazz Pharmaceuticals (JAZZ): Truist Securities Boosts Price Targ - GuruFocus

Jan 12, 2026
pulisher
Jan 12, 2026

Truist Financial Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Jazz Pharmaceuticals plcExpects to meet 2025 revenue guidanceSEC filing - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

Jazz Pharmaceuticals PLCExpects To Meet 2025 Revenue GuidanceSEC Filing - TradingView — Track All Markets

Jan 12, 2026
pulisher
Jan 12, 2026

Jazz Pharmaceuticals stock price target raised to $235 by Needham - Investing.com Nigeria

Jan 12, 2026
pulisher
Jan 12, 2026

Boehringer and Jazz to test HER2-positive breast cancer combo therapy - Investing.com UK

Jan 12, 2026
pulisher
Jan 12, 2026

Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer - The Manila Times

Jan 12, 2026
pulisher
Jan 12, 2026

What Analysts Are Saying About Jazz Pharmaceuticals Stock - Benzinga

Jan 12, 2026
pulisher
Jan 12, 2026

Needham Raises Price Target for Jazz Pharmaceuticals (JAZZ) to $235 | JAZZ Stock News - GuruFocus

Jan 12, 2026
pulisher
Jan 11, 2026

Is Jazz Pharmaceuticals (JAZZ) Offering Value After Recent Pullback And 32.7% One Year Gain - Yahoo Finance

Jan 11, 2026
pulisher
Jan 10, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Recent Share Price Weakness - Yahoo Finance

Jan 10, 2026
pulisher
Jan 10, 2026

Is Jazz Pharmaceuticals (JAZZ) Still Attractive After 33% Share Price Gain This Year? - simplywall.st

Jan 10, 2026
pulisher
Jan 10, 2026

Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates - sharewise.com

Jan 09, 2026
pulisher
Jan 09, 2026

Jazz Pharmaceuticals: A Strong Buy Due To Execution In Oncology (NASDAQ:JAZZ) - Seeking Alpha

Jan 09, 2026
pulisher
Jan 09, 2026

Jazz Pharmaceuticals touts Phase 3 zanidatamab OS win in HER2+ GEA, eyes FDA sBLA in H1 - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Jazz Pharmaceuticals (JAZZ) Is Down 5.7% After Strong Ziihera Phase 3 DataHas The Bull Case Changed? - simplywall.st

Jan 09, 2026
pulisher
Jan 09, 2026

Lecap Asset Management Ltd. Buys Shares of 6,319 Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Robeco Institutional Asset Management B.V. Cuts Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 09, 2026
pulisher
Jan 08, 2026

Why Jazz Pharmaceuticals plc stock remains resilient2025 Earnings Impact & Daily Chart Pattern Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What sentiment indicators say about Jazz Pharmaceuticals plc stockJuly 2025 WrapUp & Technical Confirmation Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Jazz pharmaceuticals appoints Thomas Riga as chief business officer By Investing.com - Investing.com South Africa

Jan 08, 2026
pulisher
Jan 08, 2026

Jazz pharmaceuticals appoints Thomas Riga as chief business officer - Investing.com

Jan 08, 2026
pulisher
Jan 08, 2026

Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer - StreetInsider

Jan 08, 2026
pulisher
Jan 08, 2026

Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer - marketscreener.com

Jan 08, 2026
pulisher
Jan 08, 2026

Should I hold or sell Jazz Pharmaceuticals plc stock in 2025Weekly Trend Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Positive Ziihera Phase 3 Gastroesophageal Cancer Results - simplywall.st

Jan 08, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$101.58
price down icon 3.31%
$33.80
price up icon 2.05%
$118.73
price down icon 0.07%
$116.68
price down icon 1.56%
$154.93
price down icon 3.49%
biotechnology ONC
$339.98
price up icon 0.16%
大文字化:     |  ボリューム (24 時間):